Herceptin plus chemo increases gastric cancer survival

01/27/2010 | MedPage Today (free registration)

Adding trastuzumab, or Herceptin, to chemotherapy for patients with advanced HER2-positive gastric cancer increases survival without a decline in quality of life, a study found. Researchers said pain scores and use of analgesics were similar between patients who received chemotherapy with or without trastuzumab.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC